Breaking News From Pharma & Bio Ingredients Subscribe via RSS Subscribe via RSS



December 2005



AZ Seeks sNDA for Bipolar Treatment


Posted on 2005-12-30 15:27:00



Valeant Gets Non-Approvable Letter for Cesamet Label


Posted on 2005-12-30 15:24:00



Par Gets OK for Generic Cefprozil


Posted on 2005-12-30 15:22:00



Genentech Seeks Priority Review for Lucentis


Posted on 2005-12-30 14:29:00



Femara Proved Effective as Breast Cancer Treatment


Posted on 2005-12-29 11:56:00



Taro and Alkem Plan Collaboration


Posted on 2005-12-29 11:51:00



Arena Earns European Patent for Insomnia Treatment


Posted on 2005-12-29 11:49:00



NitroMed and Boston Scientific Sign Pact


Posted on 2005-12-29 11:46:00



Par Gets OK for Cabergoline Tablets


Posted on 2005-12-29 11:41:00



BMS Submits NDA for Dasatinib


Posted on 2005-12-28 11:54:00



Alcoholism Drug Awaits Final Approval


Posted on 2005-12-28 11:43:00



FDA OK's MedImmune's Flu Vaccine Facility


Posted on 2005-12-27 11:38:00



NeoPharm Pleased with PRECISE Trial Results


Posted on 2005-12-27 11:36:00



Abgenix Shareholders File Suit Over Amgen Deal


Posted on 2005-12-23 11:34:00



Novavax Gets $8 Million for Estrasorb


Posted on 2005-12-23 11:31:00



Missouri AG Sues Pharma Firms for Inflated Drug Prices


Posted on 2005-12-22 10:12:00



Good Phase II Results for Hepatitis B Treatment


Posted on 2005-12-22 10:04:00



BioCryst To Test Flu Drug in Humans


Posted on 2005-12-22 10:01:00



Genzyme Acquires Avigen's Gene Therapy Technology


Posted on 2005-12-21 14:12:00



Pfizer Varenicline Receives FDA Priority Review


Posted on 2005-12-21 14:09:00



Eli Lilly Settles Charges with Guilty Plea


Posted on 2005-12-21 14:05:00



Acusphere's Phase III Trial for Al-700 Enrolls 700


Posted on 2005-12-21 14:02:00



BD Micro-Delivery System Licensed by Sanofi Pasteur


Posted on 2005-12-21 13:59:00



MGI Provides Update on Aquavan Phase II Study


Posted on 2005-12-21 13:58:00



Lawsuit Filed Over Cold Remedy


Posted on 2005-12-21 13:55:00



Biovail Gets FDA OK for Citalopram ODT


Posted on 2005-12-21 13:53:00



Rigel Advances Rheumatoid Arthritis Programs


Posted on 2005-12-20 09:46:00



CuraGen Changes Terms of Bayer Agreement


Posted on 2005-12-20 09:44:00



Penwest Gets Good Results for ER Edema Treatment


Posted on 2005-12-20 09:35:00



Mylan Signs Oxybutynin Supply Agreement with Ortho-McNeil


Posted on 2005-12-20 09:33:00



Alpharma Sells Generic Business to Actavis


Posted on 2005-12-19 09:39:00



Mylan Gets OK for Generic Zebeta


Posted on 2005-12-19 09:32:00



Barr Announces Management Change


Posted on 2005-12-19 09:29:00



Ivax Gets Approval for Schizophrenia Treatment


Posted on 2005-12-19 09:27:00



Novartis Halts Development of Cholesterol Drug


Posted on 2005-12-16 11:14:00



J&J Buys Animas for $518 Million


Posted on 2005-12-16 11:12:00



Bronchitol Begins European CF Study


Posted on 2005-12-16 10:58:00



Par To Distribute Generic Versions of Augmentin and Amoxil


Posted on 2005-12-16 10:54:00



Amarin Starts Phase III Trial of Miraxion


Posted on 2005-12-15 10:55:00



Par Begins Shipping Adoxa


Posted on 2005-12-15 10:53:00



Bird Flu Vaccine Data Looks Promising


Posted on 2005-12-15 10:52:00



GTx Reports Positive Phase III Trial for Acapodene


Posted on 2005-12-15 10:35:00



Alnylam to Tackle Pandemic Flu


Posted on 2005-12-14 12:24:00



Neurogen Begins Phase II Trial for Insomnia Drug


Posted on 2005-12-14 12:21:00



RegeneRx Gets First Chinese Patent


Posted on 2005-12-14 12:20:00



Nastech Has New Methods for Peptide and Protein Drug Delivery


Posted on 2005-12-14 12:16:00



American Pharma Gets OK for Azithromycin Injection


Posted on 2005-12-14 12:15:00



Favld Improves Cancer Drugs, Says Favrille


Posted on 2005-12-13 15:58:00



GSK and Vertex To Develop Painkiller


Posted on 2005-12-13 15:57:00



Pfizer Enlists Critic to Save Celebrex


Posted on 2005-12-13 15:51:00



Merck to Change Singulair Label


Posted on 2005-12-13 15:50:00



OxiGene Gets Cleared for Cancer Study by FDA


Posted on 2005-12-12 12:47:00



Celgene Updates Data on Myeloma Patients


Posted on 2005-12-12 12:36:00



Judge Declares Mistrial in Vioxx Trial


Posted on 2005-12-12 12:34:00



Roche Identifies Tamiflu Partners


Posted on 2005-12-12 12:26:00



Lilly To Seek New Use for Cymbalta


Posted on 2005-12-09 14:21:00



Merck's Vioxx Woes Grow


Posted on 2005-12-09 14:16:00



Vertex Hepatitis C Drug Gets Fast Track


Posted on 2005-12-09 14:11:00



Tamper-Resistant Pain Killers Posts Good Trial Results


Posted on 2005-12-08 14:13:00



Biogen Idec Chairman To Retire


Posted on 2005-12-07 14:08:00



Merck Submits Gardasil FDA Application


Posted on 2005-12-05 15:43:00



Vertex in Phase II for Hep C Treatment


Posted on 2005-12-05 15:41:00



Patch Approval Boosts Noven's Stock


Posted on 2005-12-05 15:37:00



FDA OK's Ribasphere


Posted on 2005-12-05 15:36:00



Idenix To Begin Phase III Trial for Hepatitis C Treatment


Posted on 2005-12-02 16:48:00



FTC OK's Wyeth-Teva Patent Settlement


Posted on 2005-12-02 16:45:00



Inspire's In Tears Over FDA Letter


Posted on 2005-12-02 16:42:00



BioVail Gets OK to Sell Ultram


Posted on 2005-12-02 16:39:00



PDI Sues Cellegy Over Payments


Posted on 2005-12-02 16:37:00



Akzo Nobel Settles Patent Dispute with Barr


Posted on 2005-12-02 16:35:00



Provectus Begins Phase I Breast Cancer Trial


Posted on 2005-12-01 13:51:00



R112 Study is a Disappointment for Rigel


Posted on 2005-12-01 13:47:00



Wyeth Gets $32 Million HIV Research Pact


Posted on 2005-12-01 13:46:00



Angiomax OK'd for PCI Patients


Posted on 2005-12-01 13:44:00



ArQule Submits IND for Cancer Treatment


Posted on 2005-12-01 13:42:00



Progenics Begins Trial of HIV Therapy


Posted on 2005-12-01 13:41:00



KV To Market Clindesse in Europe


Posted on 2005-12-01 13:38:00



Quigley's Compound Is Effective Against Avian Flu Virus


Posted on 2005-12-01 13:37:00



Par Pharmaceuticals Receives Tentative Approval of Generic Dostinex


Posted on 2005-12-01 13:34:00



November 2005



GSK is Focused on Oncology


Posted on 2005-11-30 13:01:00



Serologicals Earns UCOE Patent


Posted on 2005-11-30 13:00:00



J&J Asks FDA to Approve Paliperidone


Posted on 2005-11-30 12:59:00



FDA OK's Schering-Plough's Avelox


Posted on 2005-11-30 12:56:00



Carrington Earns European Patent for Delivery System


Posted on 2005-11-30 12:55:00



InSite Posts Good Results in Phase III Trial


Posted on 2005-11-30 12:53:00



Roche Signs Licensing Deal with BioCryst


Posted on 2005-11-30 12:10:00



SeraCare Acquires Serological's Celliance Assets


Posted on 2005-11-29 12:24:00



Inyx To Develop HFA Dose Inhaler


Posted on 2005-11-29 12:22:00



U.S. To Uphold Pfizer's Lipitor Patent


Posted on 2005-11-29 12:21:00



Biovail Rolls Out Glumetza in Canada


Posted on 2005-11-29 12:17:00



Mylan Gets FDA OK for Glimepiride Tablets


Posted on 2005-11-29 12:16:00



Merck Announces 7,000 Job Cuts


Posted on 2005-11-28 15:13:00



Bayer Product Gets OK from FDA


Posted on 2005-11-28 15:12:00



Depomed, Biovail Enter Term Sheet Discussions


Posted on 2005-11-28 15:10:00



Teva and IVAX Receive European Commission Approval for Acquisition


Posted on 2005-11-28 15:09:00



Enzon and Micromet End Research Collaboration


Posted on 2005-11-28 14:18:00



Merck KGaA Appoints New Chairman


Posted on 2005-11-23 10:49:00



Pexelizumab Phase III Trial Misses Mark


Posted on 2005-11-23 10:48:00



Penwest CEO Resigns


Posted on 2005-11-23 10:46:00



Depomed, Biovail Lawsuit Comes to a Standstill


Posted on 2005-11-23 10:44:00



EnteMed Announces FDA Acceptance of IND Application for ENMD-1198


Posted on 2005-11-22 14:34:00



Peregrine Gets Manufacturing Pact


Posted on 2005-11-22 14:30:00



Cell Genesys Sells Plant for $3.2 Million


Posted on 2005-11-22 14:29:00



Oxytrex Trial Fails Due to High Dropout Rate


Posted on 2005-11-22 14:27:00



Sales Surge at Interpharm


Posted on 2005-11-22 14:20:00



FDA Accepts Cubicin sNDA and Grants Priority Review


Posted on 2005-11-21 14:24:00



Par Gets OK for Ondanestron Hydrochloride Orally Disintegrating Tablets


Posted on 2005-11-21 14:18:00



Tysabri Gets Priority Review at FDA


Posted on 2005-11-17 14:22:00



Merck Completes Plant Expansion in Puerto Rico


Posted on 2005-11-16 16:18:00



Schering-Plough in Licensing Agreement


Posted on 2005-11-16 16:16:00



Abbott's Heart Drug Study Fails


Posted on 2005-11-16 16:14:00



Long-Term Study Data on Remicade Looks Positive


Posted on 2005-11-16 16:13:00



Pozen Names VP To Head Clinical Efforts


Posted on 2005-11-16 16:08:00



Miraxion Provides Neuroprotective Effects, Says Amarin


Posted on 2005-11-16 16:05:00



Talk of Spin-Off Sends Biovail Spiraling Downward


Posted on 2005-11-16 16:01:00



Good Results for Atherosclerosis Treatment


Posted on 2005-11-14 15:38:00



Teva Gets Approval for Azithromycin Tablets


Posted on 2005-11-14 15:35:00



InterMune Posts Good Results for HCV Treatment


Posted on 2005-11-14 15:32:00



Biocon To Market Intranasal Insulin Spray


Posted on 2005-11-14 15:27:00



FDA Didn't Follow Procedures in Rejecting OTC Sale of Morning-After Pill


Posted on 2005-11-14 15:25:00



Vertex Pharma Files for Mid-Stage Study


Posted on 2005-11-11 16:32:00



Andrx Comments on Court Ruling


Posted on 2005-11-11 16:25:00



Pro-Pharmaceuticals Reports 3Q Results


Posted on 2005-11-11 16:21:00



Merck Opposes Judge's Ruling Over Vioxx Cases


Posted on 2005-11-11 16:20:00



An Abuse-Resistant Painkiller is on the Way


Posted on 2005-11-10 16:28:00



AZ Files Suit Against Teva


Posted on 2005-11-09 16:30:00



Teva Gets at Lift from MS Drug


Posted on 2005-11-08 16:18:00



Ivax Reports Surge in Sales


Posted on 2005-11-08 16:13:00



Roche to Raise Production of Tamiflu


Posted on 2005-11-07 16:11:00



October 2005



Former President to Speak at DCAT Annual Dinner


Posted on 2005-10-28 11:27:00



Cambridge Major to Support Anti-Malaria Program in D.R. Congo


Posted on 2005-10-27 10:56:00



FDA Rejects J&J's Dapoxetine


Posted on 2005-10-27 09:22:00



S-P's Noxafil Oral Suspension Approved in Europe


Posted on 2005-10-27 09:19:00



Glaxo, AstraZeneca Report Increase in Earnings


Posted on 2005-10-27 09:17:00



Merck Rests Its Defense in Vioxx Trial


Posted on 2005-10-27 09:13:00



Xolair Receives Approval in Europe


Posted on 2005-10-27 09:06:00



U.S. Drug Market Expected to Grow Faster in 2006


Posted on 2005-10-27 09:00:00



Mylan Likes What FDA Has to Say about Emsam


Posted on 2005-10-27 08:34:00



Nicholas Piramal India Ltd Acquires Avecia Unit


Posted on 2005-10-27 08:13:00



RegeneRX Honored for Wound Treatment Innovation


Posted on 2005-10-26 09:31:00



Bayer, J&J to Develop Thrombosis Drug


Posted on 2005-10-26 09:28:00



Quigley Pharma's QR-442 Compound Shows Positive Effect on Multiple Sclerosis Mouse Model


Posted on 2005-10-26 09:25:00



OncoGenex Initiates Phase II Clinical Trial of OGX-011 in Cancer


Posted on 2005-10-25 17:09:00



Matrixx Reports Big Jump in Revenue


Posted on 2005-10-25 17:03:00



Mylan Laboratories Announces Executive Appointments


Posted on 2005-10-25 16:59:00



Amgen Keeps Rolling in Third


Posted on 2005-10-19 15:09:00



Guidant Says Acquisition by J&J Makes Sense


Posted on 2005-10-19 15:06:00



BioMarin Announces U.S. FDA Acceptance of Orapred ODT Filing


Posted on 2005-10-19 15:04:00



Andrx Announces ANDA Filing for Cardizem LA


Posted on 2005-10-19 15:01:00



FDA Wants More Safety Data for Pargluva


Posted on 2005-10-18 09:33:00



Second Quarter Sales and Profits Fall at Forest Labs


Posted on 2005-10-18 07:44:00



Isis Receives $7 Million from Drug Royalty USA


Posted on 2005-10-18 07:41:00



Sonus Licenses Anti-Cancer Drug to Schering AG


Posted on 2005-10-18 07:38:00



Topical Cream for Diabetic Neuropathy Looks Good in Tox Study


Posted on 2005-10-18 07:33:00



Barr To Acquire FEI Women's Health


Posted on 2005-10-18 07:29:00



Millennium Initiates Myelogenous Leukemia Trial


Posted on 2005-10-17 12:58:00



Alpharma Sells Global Generics Business to Actavis Group


Posted on 2005-10-17 12:55:00



Elan and Biogen Idec Review Tysabri Safety


Posted on 2005-10-17 12:51:00



Barr Challenges J&J Schizophrenia Patents


Posted on 2005-10-17 12:49:00



Pro-Pharmaceuticals Begins Colorectal Cancer Trial Enrollment


Posted on 2005-10-14 09:09:00



Merck Faces Surge of New Lawsuits


Posted on 2005-10-14 09:07:00



Bird Flu Found in Europe


Posted on 2005-10-13 07:38:00



Shire Petitions for Extra Testing on Adderall XR Generics


Posted on 2005-10-13 07:33:00



Inspire Provides Update on CF Research


Posted on 2005-10-13 07:30:00



J&J Files Anti-Trust Suit Against Amgen


Posted on 2005-10-13 07:26:00



Lilly Earns NCQA Certification for Disease Management Programs


Posted on 2005-10-13 07:25:00



Lilly Icos Reports Good Results on Prostate Treatment


Posted on 2005-10-12 12:54:00



Roche Collaborates to Fight Bird Flu


Posted on 2005-10-12 12:52:00



UK Court Upholds One Lipitor Patent


Posted on 2005-10-12 12:50:00



Merck Insists Vioxx Safety was Studied


Posted on 2005-10-11 12:10:00



Wyeth To Phase Out Production at Rouses Point, NY Facility


Posted on 2005-10-11 12:06:00



Watson To Close Solid Dose Facility in Puerto Rico


Posted on 2005-10-11 12:04:00



Alpharma To Test Novel Opioid Painkiller


Posted on 2005-10-10 09:09:00



Oncophage Cancer Vaccine Looks Strong


Posted on 2005-10-10 09:05:00



Sanofi-Aventis Gets OK for Ambien CR in U.S.


Posted on 2005-10-07 07:09:00



Repligen Moves to Phase II for Schizophrenia Treatment


Posted on 2005-10-07 07:07:00



Ranbaxy Wins U.S. Approval for Diabetes Drug


Posted on 2005-10-07 07:04:00



Pluristem Wins Patent for Stem Cell Technology


Posted on 2005-10-06 07:11:00



Covalent Group Wins Contract for Phase III Hypertension Drug


Posted on 2005-10-06 07:08:00



Forest and Lundbeck Settle Patent Dispute with Alphapharm


Posted on 2005-10-06 07:06:00



ZymoGenetics Gets FDA Orphan Drug Status


Posted on 2005-10-05 07:26:00



Orlando To Host 2006 Informex Show


Posted on 2005-10-05 07:26:00



AmerisourceBergen To Buy Trent Drugs


Posted on 2005-10-05 07:25:00



Positive Data from Phase III Trial of ALGRX 3268


Posted on 2005-10-05 07:22:00



Serono To Pull Out of Cancer Trials


Posted on 2005-10-04 07:50:00



Xechem Earns Orphan Drug Status in EU


Posted on 2005-10-04 07:50:00



Valeant Gets Approval for Zelapar


Posted on 2005-10-04 07:49:00



Mylan Gets FDA OK for Generic Norvasc


Posted on 2005-10-04 07:48:00



August 2005



Draxis Health 2Q Profit Rises 4 Percent


Posted on 2005-08-11 10:58:00



Barr Receives Approval for Clonazepam


Posted on 2005-08-11 10:57:00



Dyax Announces Cancer Lead


Posted on 2005-08-11 10:57:00



Theragenics Plans to Restructure Company


Posted on 2005-08-11 10:57:00



Losses Continue For BioMarin


Posted on 2005-08-03 06:19:00



Large Scale Biology Receives Orphan Status


Posted on 2005-08-03 06:18:00



Myriad's Alzheimer's Disease Test on Track


Posted on 2005-08-03 06:18:00



Abgenix drug gets fast-track OK from FDA


Posted on 2005-08-03 06:18:00



June 2005



Tysabri Shows Promise As Crohn's Treatment


Posted on 2005-06-30 06:16:00



Arena Execs Can Sleep Easier


Posted on 2005-06-30 06:16:00



Genzyme Clears Final Acquisition Hurdle


Posted on 2005-06-30 06:15:00



Teva Gets Tentative OK for Generic Amary


Posted on 2005-06-28 06:15:00



Fidelity Fund Acquires Interest in Crucell


Posted on 2005-06-28 06:14:00



SOCMA Kicks Off Booth Sales for Informex 2006


Posted on 2005-06-28 06:14:00



Eyetech Raises Macugen Sales Forecast


Posted on 2005-06-22 06:14:00



Elite and IntelliPharmaCeutics To Develop Controlled Release Product


Posted on 2005-06-22 06:13:00



Peregrine's Tarvacin Binds to 6 Viruses


Posted on 2005-06-22 06:13:00



Protein Design Inks Deal with Genentech in Deal


Posted on 2005-06-22 06:13:00



Endo Wins OxyContin Patent Suit


Posted on 2005-06-07 06:12:00



FDA Panel Splits Vote on Chiron Drug


Posted on 2005-06-07 06:12:00



Valentis Expands Licensing Agreements with Schering AG


Posted on 2005-06-07 06:12:00



Novartis Completes Hexal AG Acquisition, Integrates Company With Sandoz


Posted on 2005-06-07 06:11:00



April 2005



Senetek Extends Monoclonal Antibodies License


Posted on 2005-04-07 06:11:00



Bextra Gets Yanked from the Market


Posted on 2005-04-07 06:10:00



Serono, CancerVax Halt Clinical Trial


Posted on 2005-04-06 06:10:00



March 2005



Elan, Biogen Confirm 2nd Case of Disease


Posted on 2005-03-04 06:09:00



Vicuron Gets Novartis Milestone Payment


Posted on 2005-03-04 06:09:00



Cubist, Eli Lilly Adjust Cubicin Deal


Posted on 2005-03-03 06:08:00



Chiron Optimistic on Next Year's Flu Shot


Posted on 2005-03-03 06:08:00



February 2005



Memory Pharmaceuticals Commences Phase I Study of MEM 3454


Posted on 2005-02-25 06:07:00



Mylan FDA Nebivolol Decision Date Is Postponed by the FDA


Posted on 2005-02-25 06:07:00



Chiron Names Goldstein President, COO


Posted on 2005-02-24 06:07:00



Genzyme Begins Phase II Trial for Peripheral Arterial Disease


Posted on 2005-02-24 06:06:00



James D. Watson Helix Awards Honor Biotech's Top Performers


Posted on 2005-02-24 06:06:00



DOV Initiates Phase I Trial for Depression


Posted on 2005-02-24 06:06:00



European Commission Approves Truvada


Posted on 2005-02-23 06:05:00



Memory Launches PDE10A Inhibitor Program


Posted on 2005-02-23 06:05:00



Watson Pharmaceuticals Fourth-Quarter Earnings Grow 4 Percent


Posted on 2005-02-11 06:04:00



BioProgress Earns Patent for Oral Dosage


Posted on 2005-02-11 06:04:00



Mylan Gets Tentative Approval for Wake-Up Pill


Posted on 2005-02-11 06:03:00



Cephalon Says Nuvigil Drug Improved Wakefulness in Late-Stage Trial


Posted on 2005-02-10 06:03:00



2004 Sales Surge for Genaissance Pharmaceuticals


Posted on 2005-02-10 06:01:00



Generex Biotechnology To Develop Small Pox Vaccine


Posted on 2005-02-10 06:00:00



Clinical Trial Set for Oral Spray to Reduce Chemotherapy-Induced Nausea


Posted on 2005-02-09 15:46:00



Testosterone Spray Improves Sexual Desire in Women


Posted on 2005-02-09 15:46:00



Inspire Says Dry-Eye Treatment Fails to Meet Trial Goals


Posted on 2005-02-09 15:46:00



Court Rules for Barr in Patent Suit


Posted on 2005-02-09 15:45:00



Rhodia Pharma Solutions, Critical Therapeutics Sign Pact


Posted on 2005-02-09 15:44:00



NEWS ARCHIVES

2008

2007

2006

2005

2004

NEWSLETTER SIGNUP